Frankfurt - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.F)
12.88
+1.51
+(13.24%)
As of 8:18:00 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COOK JENNIFER E Director | Sale | Jun 6, 2024 | 20,038 |
| FLATLEY JAY T Director | Stock Award(Grant) | May 31, 2024 | 346,496 |
| HO CAROLE Officer | Sale | Jan 7, 2025 | 383,892 |
| KLEIN PETER S Director | Stock Award(Grant) | May 31, 2024 | 21,496 |
| KROGNES STEVE E Director | Sale | Jan 7, 2025 | 807,554 |
| SATO VICKI LEE Director | Sale | Jan 2, 2025 | 107,976 |
| SCHENKEIN DAVID P Director | Conversion of Exercise of derivative security | Nov 11, 2024 | 66,684 |
| SCHUTH ALEXANDER O Chief Operating Officer | Sale | Jan 7, 2025 | 768,057 |
| TESSIER LAVIGNE MARC T Director | Stock Award(Grant) | May 31, 2024 | 2,117,410 |
| WATTS RYAN J Chief Executive Officer | Sale | Jan 7, 2025 | 2,455,680 |
Related Tickers
BH3.F PTC Therapeutics, Inc.
42.80
+3.38%
HALB Halberd Corporation
0.0024
+33.33%
APRE Aprea Therapeutics, Inc.
1.5450
+5.10%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2256
+6.87%
GNLX Genelux Corporation
2.9400
+8.89%
IMCR Immunocore Holdings plc
29.52
+0.37%
ACET Adicet Bio, Inc.
0.5817
+2.34%
ENZC Enzolytics, Inc.
0.0006
-14.29%
ZYME Zymeworks Inc.
12.16
+3.49%
ACRV Acrivon Therapeutics, Inc.
2.0300
+6.28%